Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer: toxicity profile and early oncologic outcomes.

Hwang ME, Mayeda M, Liz M, Goode-Marshall B, Gonzalez L, Elliston CD, Spina CS, Padilla OA, Wenske S, Deutsch I.

Radiat Oncol. 2019 Aug 2;14(1):136. doi: 10.1186/s13014-019-1346-5.

2.

Oxidative modification of skin lipids by cold atmospheric plasma (CAP): A standardizable approach using RP-LC/MS2 and DI-ESI/MS2.

Striesow J, Lackmann JW, Ni Z, Wenske S, Weltmann KD, Fedorova M, von Woedtke T, Wende K.

Chem Phys Lipids. 2019 Jun 20:104786. doi: 10.1016/j.chemphyslip.2019.104786. [Epub ahead of print]

PMID:
31229410
3.

The Prevalence of Bladder Cancer During Cystoscopy for Asymptomatic Microscopic Hematuria.

Gonzalez AN, Lipsky MJ, Li G, Rutman MP, Cooper KL, Weiner DM, Badalato G, Decastro GJ, Wenske S, McKiernan JM, Anderson CB.

Urology. 2019 Apr;126:34-38. doi: 10.1016/j.urology.2019.01.011. Epub 2019 Jan 22.

PMID:
30677457
4.

A novel model to correlate hydrogel spacer placement, perirectal space creation, and rectum dosimetry in prostate stereotactic body radiotherapy.

Hwang ME, Black PJ, Elliston CD, Wolthuis BA, Smith DR, Wu CC, Wenske S, Deutsch I.

Radiat Oncol. 2018 Oct 1;13(1):192. doi: 10.1186/s13014-018-1135-6.

5.

Assessment of Discomfort and Pain in Patients Undergoing Fusion Magnetic Resonance Imaging-guided vs TRUS-guided Prostate Biopsy.

Robins D, Lipsky M, RoyChoudry A, Wenske S.

Urology. 2018 Jun;116:30-34. doi: 10.1016/j.urology.2018.02.029. Epub 2018 Mar 12.

PMID:
29545039
6.

Impact of a Structured Reporting Template on Adherence to Prostate Imaging Reporting and Data System Version 2 and on the Diagnostic Performance of Prostate MRI for Clinically Significant Prostate Cancer.

Shaish H, Feltus W, Steinman J, Hecht E, Wenske S, Ahmed F.

J Am Coll Radiol. 2018 May;15(5):749-754. doi: 10.1016/j.jacr.2018.01.034. Epub 2018 Mar 2.

PMID:
29506919
7.

Development of a Nationally Representative Coordinated Registry Network for Prostate Ablation Technologies.

Golan R, Bernstein A, Sedrakyan A, Daskivich TJ, Du DT, Ehdaie B, Fisher B, Gorin MA, Grunberger I, Hunt B, Jiang HH, Kim HL, Marinac-Dabic D, Marks LS, McClure TD, Montgomery JS, Parekh DJ, Punnen S, Scionti S, Viviano CJ, Wei JT, Wenske S, Wysock JS, Rewcastle J, Carol M, Oczachowski M, Hu JC.

J Urol. 2018 Jun;199(6):1488-1493. doi: 10.1016/j.juro.2017.12.058. Epub 2018 Jan 4.

PMID:
29307684
8.

Oncologic Outcomes of Definitive Treatments for Low- and Intermediate-Risk Prostate Cancer After a Period of Active Surveillance.

Whalen MJ, Pak JS, Lascano D, Ahlborn D, Matulay JT, McKiernan JM, Benson MC, Wenske S.

Clin Genitourin Cancer. 2018 Apr;16(2):e425-e435. doi: 10.1016/j.clgc.2017.10.007. Epub 2017 Oct 16.

PMID:
29113772
9.

Timing and Predictors of Early Urologic and Infectious Complications After Renal Transplant: An Analysis of a New York Statewide Database.

Sui W, Lipsky MJ, Matulay JT, Robins DJ, Onyeji IC, James MB, Theofanides MC, Wenske S.

Exp Clin Transplant. 2018 Dec;16(6):665-670. doi: 10.6002/ect.2016.0357. Epub 2017 Jul 11.

10.

Collecting duct carcinoma of the kidney: Disease characteristics and treatment outcomes from the National Cancer Database.

Sui W, Matulay JT, Robins DJ, James MB, Onyeji IC, RoyChoudhury A, Wenske S, DeCastro GJ.

Urol Oncol. 2017 Sep;35(9):540.e13-540.e18. doi: 10.1016/j.urolonc.2017.04.010. Epub 2017 May 8.

PMID:
28495554
11.

Predictors of biochemical recurrence after primary focal cryosurgery (hemiablation) for localized prostate cancer: A multi-institutional analytic comparison of Phoenix and Stuttgart criteria.

Kongnyuy M, Lipsky MJ, Islam S, Robins DJ, Hager S, Halpern DM, Kosinski KE, Schiff JT, Corcoran AT, Wenske S, Katz AE.

Urol Oncol. 2017 Aug;35(8):530.e15-530.e19. doi: 10.1016/j.urolonc.2017.03.016. Epub 2017 Apr 11.

PMID:
28410986
12.

Micropapillary Bladder Cancer: Insights from the National Cancer Database.

Sui W, Matulay JT, James MB, Onyeji IC, Theofanides MC, RoyChoudhury A, DeCastro GJ, Wenske S.

Bladder Cancer. 2016 Oct 27;2(4):415-423. doi: 10.3233/BLC-160066.

13.

Contemporary treatment patterns and outcomes of sarcomatoid bladder cancer.

Sui W, Matulay JT, Onyeji IC, Theofanides MC, James MB, RoyChoudhury A, Wenske S, DeCastro GJ.

World J Urol. 2017 Jul;35(7):1055-1061. doi: 10.1007/s00345-016-1962-8. Epub 2016 Nov 1.

PMID:
27803966
14.

Outcomes and Prognostic Factors of Primary Urethral Cancer.

Sui W, RoyChoudhury A, Wenske S, Decastro GJ, McKiernan JM, Anderson CB.

Urology. 2017 Feb;100:180-186. doi: 10.1016/j.urology.2016.09.042. Epub 2016 Oct 5.

PMID:
27720774
15.

Perioperative blood transfusion predicts short term morbidity after nephrectomy.

Sui W, Onyeji IC, Matulay JT, Theofanides MC, James MB, DeCastro GJ, Wenske S.

Can J Urol. 2016 Aug;23(4):8348-55.

PMID:
27544557
16.

Perioperative blood transfusion in radical cystectomy: Analysis of the National Surgical Quality Improvement Program database.

Sui W, Onyeji IC, Matulay JT, James MB, Theofanides MC, Wenske S, DeCastro GJ.

Int J Urol. 2016 Sep;23(9):745-50. doi: 10.1111/iju.13152. Epub 2016 Jul 11.

17.

Analysis of uroflow patterns in children with dysfunctional voiding.

Wenske S, Van Batavia JP, Combs AJ, Glassberg KI.

J Pediatr Urol. 2014 Apr;10(2):250-4. doi: 10.1016/j.jpurol.2013.10.010. Epub 2013 Nov 7.

PMID:
24290223
18.

A molecular signature predictive of indolent prostate cancer.

Irshad S, Bansal M, Castillo-Martin M, Zheng T, Aytes A, Wenske S, Le Magnen C, Guarnieri P, Sumazin P, Benson MC, Shen MM, Califano A, Abate-Shen C.

Sci Transl Med. 2013 Sep 11;5(202):202ra122. doi: 10.1126/scitranslmed.3006408. Erratum in: Sci Transl Med. 2013 Sep 18;5(203):203er9.

19.
20.

Outcomes of distal ureteral reconstruction through reimplantation with psoas hitch, Boari flap, or ureteroneocystostomy for benign or malignant ureteral obstruction or injury.

Wenske S, Olsson CA, Benson MC.

Urology. 2013 Jul;82(1):231-6. doi: 10.1016/j.urology.2013.02.046. Epub 2013 May 2.

PMID:
23642933
21.
22.

Can staccato and interrupted/fractionated uroflow patterns alone correctly identify the underlying lower urinary tract condition?

Wenske S, Combs AJ, Van Batavia JP, Glassberg KI.

J Urol. 2012 Jun;187(6):2188-93. doi: 10.1016/j.juro.2012.01.126. Epub 2012 Apr 12.

PMID:
22503030
23.

An evaluation of patient selection criteria on predicting progression-free survival after primary focal unilateral nerve-sparing cryoablation for prostate cancer: recommendations for follow up.

Truesdale MD, Cheetham PJ, Hruby GW, Wenske S, Conforto AK, Cooper AB, Katz AE.

Cancer J. 2010 Sep-Oct;16(5):544-9. doi: 10.1097/PPO.0b013e3181f84639.

PMID:
20890154
24.

Long-term cancer-specific and overall survival for men followed more than 10 years after primary and salvage cryoablation of the prostate.

Cheetham P, Truesdale M, Chaudhury S, Wenske S, Hruby GW, Katz A.

J Endourol. 2010 Jul;24(7):1123-9. doi: 10.1089/end.2010.0130.

PMID:
20575687
25.

NF-kappaB regulates androgen receptor expression and prostate cancer growth.

Zhang L, Altuwaijri S, Deng F, Chen L, Lal P, Bhanot UK, Korets R, Wenske S, Lilja HG, Chang C, Scher HI, Gerald WL.

Am J Pathol. 2009 Aug;175(2):489-99. doi: 10.2353/ajpath.2009.080727. Epub 2009 Jul 23.

26.

Open radical retropubic prostatectomy gives favourable surgical and functional outcomes after transurethral resection of the prostate.

Palisaar JR, Wenske S, Sommerer F, Hinkel A, Noldus J.

BJU Int. 2009 Sep;104(5):611-5. doi: 10.1111/j.1464-410X.2009.08474.x. Epub 2009 Mar 4.

27.

Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival.

Helo P, Cronin AM, Danila DC, Wenske S, Gonzalez-Espinoza R, Anand A, Koscuiszka M, Väänänen RM, Pettersson K, Chun FK, Steuber T, Huland H, Guillonneau BD, Eastham JA, Scardino PT, Fleisher M, Scher HI, Lilja H.

Clin Chem. 2009 Apr;55(4):765-73. doi: 10.1373/clinchem.2008.117952. Epub 2009 Feb 20.

28.

Evaluation of molecular forms of prostate-specific antigen and human kallikrein 2 in predicting biochemical failure after radical prostatectomy.

Wenske S, Korets R, Cronin AM, Vickers AJ, Fleisher M, Scher HI, Pettersson K, Guillonneau B, Scardino PT, Eastham JA, Lilja H.

Int J Cancer. 2009 Feb 1;124(3):659-63. doi: 10.1002/ijc.23983.

29.

[Impact of elastography in clinical diagnosis of prostate cancer. A comparison of cancer detection between B-mode sonography and elastography-guided 10-core biopsies].

Eggert T, Khaled W, Wenske S, Ermert H, Noldus J.

Urologe A. 2008 Sep;47(9):1212-7. doi: 10.1007/s00120-008-1838-7. German.

PMID:
18704361
30.

Ileoanal-pouch reconstruction does not impair sphincter function or quality of life.

Gawad KA, Wenske S, von Schrenck T, Izbicki JR.

Hepatogastroenterology. 2007 Jul-Aug;54(77):1477-82.

PMID:
17708280
31.

Elevation of asymmetrical dimethylarginine (ADMA) and coronary artery disease in men with erectile dysfunction.

Maas R, Wenske S, Zabel M, Ventura R, Schwedhelm E, Steenpass A, Klemm H, Noldus J, Böger RH.

Eur Urol. 2005 Dec;48(6):1004-11; discussion 1011-2. Epub 2005 Aug 15.

PMID:
16139418
32.

Comparison of accuracy between the Partin tables of 1997 and 2001 to predict final pathological stage in clinically localized prostate cancer.

Augustin H, Eggert T, Wenske S, Karakiewicz PI, Palisaar J, Daghofer F, Huland H, Graefen M.

J Urol. 2004 Jan;171(1):177-81.

PMID:
14665871

Supplemental Content

Loading ...
Support Center